Medivis, a New York-based medical technology company utilizing augmented reality and artificial intelligence to advance surgical visualization, has announced that its augmented reality surgical system technology platform, SurgicalAR, received U.S. FDA 510(k) clearance for clinical use in the operating room.

The enterprise SurgicalAR platform integrates the latest advancements in augmented reality, artificial intelligence, and computer vision to advance surgical visualization, thereby decreasing surgical complications and improving patient outcomes—all while lowering costs to the healthcare system.

“Holographic visualization is the final frontier of surgical imaging and navigation,” notes Osamah Choudhry, MD, neurosurgeon, and CEO of Medivis. “The surgical world continues to primarily rely on two-dimensional imaging technology to understand and operate on incredibly complex patient pathology.”

This announcement comes on the heels of significant company momentum, including strategic partnerships with Verizon and Microsoft. Earlier this year, the company came out of stealth with $2.3 million in funding, led by Initialized Capital. The company also recently released their AnatomyX platform for AR medical training.

“Medical imaging for invasive surgical procedures has been waiting for a transformation like this for decades —and we knew from day one that Medivis would be the leader in this emerging space,” says Eric Woersching, general partner, Initialized Capital.